UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The molecular landscape of head and neck cancer

Nature reviews. Cancer, 2018-05, Vol.18 (5), p.269-282

2018

Volltextzugriff (PDF)

Head and neck squamous cell carcinoma

Nature reviews. Disease primers, 2020-11, Vol.6 (1), p.92, Article 92

2020

Volltextzugriff (PDF)

The molecular biology of head and neck cancer

Nature reviews. Cancer, 2011-01, Vol.11 (1), p.9-22

2011

Volltextzugriff (PDF)

Adenoid cystic carcinoma of the head and neck: A single-center analysis of 105 consecutive cases over a 30-year period

Oral oncology, 2013-08, Vol.49 (8), p.824-829

2013

Volltextzugriff (PDF)

Global incidence of oral and oropharynx cancer in patients younger than 45 years versus older patients: A systematic review

European journal of cancer (1990), 2017-09, Vol.82, p.115-127

2017

Volltextzugriff (PDF)

A review of the most promising biomarkers for early diagnosis and prognosis prediction of tongue squamous cell carcinoma

British journal of cancer, 2018-09, Vol.119 (6), p.724-736

2018

Volltextzugriff (PDF)

Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach

Nature communications, 2014-06, Vol.5 (1), p.4006-4006, Article 4006

2014

Volltextzugriff (PDF)

The Immune Microenvironment in Head and Neck Squamous Cell Carcinoma: on Subsets and Subsites

Current oncology reports, 2020-06, Vol.22 (8), p.81-81, Article 81

2020

Volltextzugriff (PDF)

Incidence and survival trends of head and neck squamous cell carcinoma in the Netherlands between 1989 and 2011

Oral oncology, 2014-07, Vol.50 (7), p.670-675

2014

Volltextzugriff (PDF)

Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial

The Lancet (British edition), 2019-01, Vol.393 (10166), p.51-60

2019

Volltextzugriff (PDF)

Improved tumor targeting of anti–epidermal growth factor receptor Nanobodies through albumin binding: taking advantage of modular Nanobody technology

Molecular cancer therapeutics, 2008-08, Vol.7 (8), p.2288-2297

2008

Volltextzugriff (PDF)

Histopathological grading of adenoid cystic carcinoma of the head and neck: Analysis of currently used grading systems and proposal for a simplified grading scheme

Oral oncology, 2015-01, Vol.51 (1), p.71-76

2015

Volltextzugriff (PDF)

Increasing prevalence rates of HPV attributable oropharyngeal squamous cell carcinomas in the Netherlands as assessed by a validated test algorithm

International journal of cancer, 2013-04, Vol.132 (7), p.1565-1571

2013

Volltextzugriff (PDF)

Critical Issues in Head and Neck Oncology: Key Concepts from the Eighth THNO Meeting

1st Edition 2023, 2023

Volltextzugriff (PDF)

The association between health related quality of life and survival in patients with head and neck cancer: A systematic review

Oral oncology, 2015-01, Vol.51 (1), p.1-11

2015

Volltextzugriff (PDF)

A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen

International journal of cancer, 2007-12, Vol.121 (11), p.2465-2472

2007

Volltextzugriff (PDF)

Outcome prediction of head and neck squamous cell carcinoma by MRI radiomic signatures

European radiology, 2020-11, Vol.30 (11), p.6311-6321

2020

Volltextzugriff (PDF)

Intensity-Modulated Radiotherapy Reduces Radiation-Induced Morbidity and Improves Health-Related Quality of Life: Results of a Nonrandomized Prospective Study Using a Standardized Follow-Up Program

International journal of radiation oncology, biology, physics, 2009-05, Vol.74 (1), p.1-8

2009

Volltextzugriff (PDF)

Molecular characterization of p16‐immunopositive but HPV DNA‐negative oropharyngeal carcinomas

International journal of cancer, 2014-05, Vol.134 (10), p.2366-2372

2014

Volltextzugriff (PDF)

Development of a multivariable normal tissue complication probability (NTCP) model for tube feeding dependence after curative radiotherapy/chemo-radiotherapy in head and neck cancer

Radiotherapy and oncology, 2014-10, Vol.113 (1), p.95-101

2014

Volltextzugriff (PDF)

Salvage surgery in head and neck cancer

Oral diseases, 2021-01, Vol.27 (1), p.117-124

2021

Volltextzugriff (PDF)

Treatment choice for locally advanced head and neck cancers on the basis of risk factors: biological risk factors

Annals of oncology, 2012-09, Vol.23 Suppl 10, p.x173-x177

2012

Volltextzugriff (PDF)

Poor sleep quality among newly diagnosed head and neck cancer patients: prevalence and associated factors

Supportive care in cancer, 2021-02, Vol.29 (2), p.1035-1045

2021

Volltextzugriff (PDF)

A Phase I Dose Escalation Study with Anti-CD44v6 Bivatuzumab Mertansine in Patients with Incurable Squamous Cell Carcinoma of the Head and Neck or Esophagus

Clinical cancer research, 2006-10, Vol.12 (20), p.6064-6072

2006

Volltextzugriff (PDF)

Employment and return to work in head and neck cancer survivors

Oral oncology, 2010-01, Vol.46 (1), p.56-60

2010

Volltextzugriff (PDF)

1 – 25 von 600

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(478)
Mit Volltextzugriff
(573)

Publikationsform

Artikel
(475)
Buchkapitel
(115)
Bücher
(8)
Berichte
(2)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

The molecular landscape of head and neck cancer

Head and neck squamous cell carcinoma

The molecular biology of head and neck cancer

Adenoid cystic carcinoma of the head and neck: A single-center analysis of 105 consecutive cases over a 30-year period

Global incidence of oral and oropharynx cancer in patients younger than 45 years versus older patients: A systematic review

A review of the most promising biomarkers for early diagnosis and prognosis prediction of tongue squamous cell carcinoma

Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach

The Immune Microenvironment in Head and Neck Squamous Cell Carcinoma: on Subsets and Subsites

Incidence and survival trends of head and neck squamous cell carcinoma in the Netherlands between 1989 and 2011

Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial

Improved tumor targeting of anti–epidermal growth factor receptor Nanobodies through albumin binding: taking advantage of modular Nanobody technology

Histopathological grading of adenoid cystic carcinoma of the head and neck: Analysis of currently used grading systems and proposal for a simplified grading scheme

Increasing prevalence rates of HPV attributable oropharyngeal squamous cell carcinomas in the Netherlands as assessed by a validated test algorithm

Critical Issues in Head and Neck Oncology: Key Concepts from the Eighth THNO Meeting

The association between health related quality of life and survival in patients with head and neck cancer: A systematic review

A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen

Outcome prediction of head and neck squamous cell carcinoma by MRI radiomic signatures

Intensity-Modulated Radiotherapy Reduces Radiation-Induced Morbidity and Improves Health-Related Quality of Life: Results of a Nonrandomized Prospective Study Using a Standardized Follow-Up Program

Molecular characterization of p16‐immunopositive but HPV DNA‐negative oropharyngeal carcinomas

Development of a multivariable normal tissue complication probability (NTCP) model for tube feeding dependence after curative radiotherapy/chemo-radiotherapy in head and neck cancer

Salvage surgery in head and neck cancer

Treatment choice for locally advanced head and neck cancers on the basis of risk factors: biological risk factors

Poor sleep quality among newly diagnosed head and neck cancer patients: prevalence and associated factors

A Phase I Dose Escalation Study with Anti-CD44v6 Bivatuzumab Mertansine in Patients with Incurable Squamous Cell Carcinoma of the Head and Neck or Esophagus

Employment and return to work in head and neck cancer survivors

Suchergebnisse filtern